메뉴 건너뛰기




Volumn 56, Issue 12, 2002, Pages 899-902

Cancer screening

Author keywords

[No Author keywords available]

Indexed keywords

CANCER;

EID: 0036898030     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.56.12.899     Document Type: Review
Times cited : (34)

References (26)
  • 1
    • 18044399420 scopus 로고    scopus 로고
    • Guidance on terminology
    • Wald NJ. Guidance on terminology. J Med Screen 2001;8:56.
    • (2001) J Med Screen , vol.8 , pp. 56
    • Wald, N.J.1
  • 3
    • 0023801733 scopus 로고
    • Mammagraphic screening and mortality from breast cancer: The Malmo mammographlc screening trial
    • Andersson I, Aspegren K, Janzon L. Mammagraphic screening and mortality from breast cancer: The Malmo mammographlc screening trial. BMJ 1988;297:943-8.
    • (1988) BMJ , vol.297 , pp. 943-948
    • Andersson, I.1    Aspegren, K.2    Janzon, L.3
  • 4
    • 0033026235 scopus 로고    scopus 로고
    • Users' guides to the medical literature. XVII. How to use guidelines and recommendations about screening
    • Barratt A, Irwig L, Glasziou P, et al. Users' guides to the medical literature. XVII. How to use guidelines and recommendations about screening. JAMA 1999;281:2029-34.
    • (1999) JAMA , vol.281 , pp. 2029-2034
    • Barratt, A.1    Irwig, L.2    Glasziou, P.3
  • 5
    • 0019976346 scopus 로고
    • Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results
    • Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982;248:1465-77.
    • (1982) JAMA , vol.248 , pp. 1465-1477
  • 6
    • 85047692188 scopus 로고
    • Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
    • Schulz KF, Chalmers I. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
    • (1995) JAMA , vol.273 , pp. 408-412
    • Schulz, K.F.1    Chalmers, I.2
  • 7
    • 0035922670 scopus 로고    scopus 로고
    • Cochrane review on screening for breast cancer with mammagraphy
    • Olsen O, Gøtzsche P. Cochrane review on screening for breast cancer with mammagraphy. Lancet 2001;358:1340-2.
    • (2001) Lancet , vol.358 , pp. 1340-1342
    • Olsen, O.1    Gøtzsche, P.2
  • 8
    • 0032562004 scopus 로고    scopus 로고
    • New test in cervical screening
    • Raffle A. New test in cervical screening. Lancet 1998;351:297.
    • (1998) Lancet , vol.351 , pp. 297
    • Raffle, A.1
  • 10
    • 0035019336 scopus 로고    scopus 로고
    • Information about screening - Is it to achieve high uptake or to ensure informed choice?
    • Raffle A. Information about screening - Is it to achieve high uptake or to ensure informed choice? Health Expectations 2001;4:92-8.
    • (2001) Health Expectations , vol.4 , pp. 92-98
    • Raffle, A.1
  • 11
    • 0033519080 scopus 로고    scopus 로고
    • Effect of screening on incidence and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics
    • Quinn M, Babb P, Jones J, et al. Effect of screening on incidence and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics. BMJ 1999;318:904-15.
    • (1999) BMJ , vol.318 , pp. 904-915
    • Quinn, M.1    Babb, P.2    Jones, J.3
  • 12
    • 0025217080 scopus 로고
    • Women's attitudes to screening after participation in the National Breast Screening Study
    • Baines C, To T, Wall C. Women's attitudes to screening after participation in the National Breast Screening Study. A Questionnaire Survey Cancer 1990;65:1663-9.
    • (1990) A Questionnaire Survey Cancer , vol.65 , pp. 1663-1669
    • Baines, C.1    To, T.2    Wall, C.3
  • 13
    • 0036179998 scopus 로고    scopus 로고
    • A population-based, community estimate of total colon examination: The impact on compliance with screening for colorectal cancer
    • Schoen RE, Weissfeld JL, Trauss JM. A population-based, community estimate of total colon examination: The impact on compliance with screening for colorectal cancer. Am J Gastroenterol 2002;97:446-51.
    • (2002) Am J Gastroenterol , vol.97 , pp. 446-451
    • Schoen, R.E.1    Weissfeld, J.L.2    Trauss, J.M.3
  • 14
    • 0034039094 scopus 로고    scopus 로고
    • False-negative results in screening programmes: Systematic review of impact and implications
    • Petticrew MP, Sowden AJ, Lister-Sharp D, et al. False-negative results in screening programmes: Systematic review of impact and implications. Health Technol Assess 2000;4:1-120.
    • (2000) Health Technol Assess , vol.4 , pp. 1-120
    • Petticrew, M.P.1    Sowden, A.J.2    Lister-Sharp, D.3
  • 15
    • 0025296101 scopus 로고
    • Comparing benefits and harms: The balance sheet
    • Eddy D. Comparing benefits and harms: The balance sheet. JAMA 1990;263:2493-8.
    • (1990) JAMA , vol.263 , pp. 2493-2498
    • Eddy, D.1
  • 16
    • 0033676437 scopus 로고    scopus 로고
    • Telling people about screening programmes and screening test results; how can we do it better?
    • Goyder E, Barratt A, Irwig L. Telling people about screening programmes and screening test results; how can we do it better? J Med Screen 2000;7:123-6.
    • (2000) J Med Screen , vol.7 , pp. 123-126
    • Goyder, E.1    Barratt, A.2    Irwig, L.3
  • 18
    • 0028006259 scopus 로고
    • An economic view of high compliance as a screening objective
    • Torgenson D, Donaldson C. An economic view of high compliance as a screening objective. BMJ 1994;308:117-9.
    • (1994) BMJ , vol.308 , pp. 117-119
    • Torgenson, D.1    Donaldson, C.2
  • 19
    • 0032988418 scopus 로고    scopus 로고
    • Women must be given fully informed information about cervical screening
    • Nottingham J. Women must be given fully informed information about cervical screening. BMJ 1999;318:1555-6.
    • (1999) BMJ , vol.318 , pp. 1555-1556
    • Nottingham, J.1
  • 20
    • 0032067524 scopus 로고    scopus 로고
    • Evidence-based screening: What kind of evidence is needed?
    • Fletcher S. Evidence-based screening: What kind of evidence is needed? ACP Journal Club 1998;128:A12-14
    • (1998) ACP Journal Club , vol.128
    • Fletcher, S.1
  • 21
    • 0026444054 scopus 로고
    • Meta-analysis adjusting for compliance: The example of screening for breast cancer
    • Glasziou P. Meta-analysis adjusting for compliance: The example of screening for breast cancer. J Clin Epidemiol 1992;45:1251-6.
    • (1992) J Clin Epidemiol , vol.45 , pp. 1251-1256
    • Glasziou, P.1
  • 22
    • 0021027662 scopus 로고
    • Estimation of the duration of a pre-clinical disease state using screening data
    • Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol 1983;118:865-86.
    • (1983) Am J Epidemiol , vol.118 , pp. 865-886
    • Walter, S.D.1    Day, N.E.2
  • 25
    • 0034805885 scopus 로고    scopus 로고
    • Screening and the number needed to treat
    • Richardson A. Screening and the number needed to treat. J Med Screen 2001;8:125-7.
    • (2001) J Med Screen , vol.8 , pp. 125-127
    • Richardson, A.1
  • 26
    • 0034805659 scopus 로고    scopus 로고
    • The number needed to screen - An adaptation of the number needed to treat
    • Law MR. The number needed to screen - An adaptation of the number needed to treat. J Med Screen 2001;8:114-15.
    • (2001) J Med Screen , vol.8 , pp. 114-115
    • Law, M.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.